Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights

NEXT STORY
Zivo Bioscience, Inc. Issues Letter to Shareholders
PREV STORY
Impact of COVID-19 Pandemic on Funding and Reimbursement of Pharmaceuticals and Vaccines
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Call for Submissions Open for the 2018 $100,000 Hearst Health Prize in Partnership With the Jefferson College of Population Health

NEW YORK, NY and PHILADELPHIA, PA--(Marketwired - May 02, 2017) - Hearst Health, a ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Selected as One of Chicago Tribune’s 2016 Top Workplaces

LAKE FOREST, Ill., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) a biopharmaceutical ...

author_avatar
NASDAQ Market News

Celyad Announces Third Quarter 2017 Business Update

MONT-SAINT-GUIBERT, Belgium, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News